Treatment response and survival according to molecular alterations in 229 patients with high-grade gastroenteropancreatic neuroendocrine neoplasms (HG GEP-NEN)

被引：0
|
作者：
Elvebakken, H. [1 ]
Venizelos, A. [2 ]
Perren, A. [3 ]
Couvelard, A. [4 ]
Lothe, I. M. [5 ]
Hjortland, G. O. [6 ]
Sundlov, A. [7 ]
Garresori, H. [8 ]
Hofsli, E. [9 ]
Krogh, M. [10 ]
Knappskog, S. [2 ]
Sorbye, H. [11 ,12 ]
机构：
[1] Alesund Hosp, Dept Oncol, Alesund, Norway
[2] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Genome Directed Canc Therapy, Bergen, Norway
[3] Univ Bern, Inst Pathol, Bern, Switzerland
[4] Univ Paris, Bichat Hosp, Dept Pathol, Paris, France
[5] Oslo Univ Hosp, Dept Pathol, Oslo, Norway
[6] Oslo Univ Hosp, Dept Oncol, Oslo, Norway
[7] Skane Univ Hosp, Dept Oncol, Lund, Sweden
[8] Stavanger Univ Hosp, Dept Oncol, Stavanger, Norway
[9] St Olavs Hosp, Dept Oncol, Trondheim, Norway
[10] Odense Univ Hosp, Dept Oncol, Odense, Denmark
[11] Univ Bergen, Dept Oncol, Haukeland Univ Hosp, Bergen, Norway
[12] Univ Bergen, Dept Clin Sci, Bergen, Norway
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2022年 / 34卷
关键词：
neuroendocrine neoplasm; neuroendocrine carcinoma; high-grade; gastroenteropancreatic; molecular alteration; molecular marker;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F05
引用
收藏
页码：106 / 106
页数：1
相关论文
共 45 条
  • [1] Prognostic Value of Systemic Inflammatory Response Markers in Highly Proliferative Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN)
    Rosery, Vivian Katrin
    Cheung, Phyllis
    Mika, Stephan
    Stuschkes, Martin
    Paul, Andreas
    Reis, Henning
    Siveke, Jens
    Schuler, Martin
    Kasper, Stefan
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 222 - 223
  • [2] Molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
    Sorbye, H.
    Venizelos, A.
    Elvebakken, H.
    Perren, A.
    Lothe, I. M. B.
    Hjortland, G. O.
    Sundlov, A.
    Svensson, J.
    Garresori, H.
    Kersten, C.
    Krogh, M.
    Detlefsen, S.
    Knappskog, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S910 - S911
  • [3] The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
    Venizelos, Andreas
    Elvebakken, Hege
    Perren, Aurel
    Nikolaienko, Oleksii
    Deng, Wei
    Lothe, Inger Marie B.
    Couvelard, Anne
    Hjortland, Geir Olav
    Sundlov, Anna
    Svensson, Johanna
    Garresori, Harrish
    Kersten, Christian
    Hofsli, Eva
    Detlefsen, Sonke
    Krogh, Merete
    Sorbye, Halfdan
    Knappskog, Stian
    ENDOCRINE-RELATED CANCER, 2022, 29 (01) : 1 - 14
  • [4] A Consensus Developed Morphological Re-evaluation of 196 Cases with Metastatic High-grade Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN G3) from the Nordic NEC Registries: Consequences for Classification, Treatment Response and Survival
    Elvebakken, H.
    Perren, A.
    Scoazec, J. Y.
    Tang, L. H.
    Federspiel, B.
    Vestermark, L.
    Zlobec, I
    Hjortland, G. O.
    Langer, S. W.
    Gronbaek, H.
    Janson, Tiensuu E.
    Sorbye, H.
    NEUROENDOCRINOLOGY, 2019, 108 : 149 - 149
  • [5] Therapeutic Strategies in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN): Results from the National Neuroendocrine Cancer Registry of Spain (R-GETNE)
    Nunez, B.
    Castano, A.
    Teule Vega, A.
    Marazuela Azpiroz, M.
    Medina, K.
    Segura, A.
    Villabona, C.
    Benavent, M.
    Lopez, C.
    Alonso Gordoa, T.
    Capdevila, J.
    Alonso Orduna, V
    Carmona-Bayonas, A.
    Garcia Carbonero, R.
    Jimenez-Fonseca, P.
    NEUROENDOCRINOLOGY, 2016, 103 : 89 - 89
  • [6] Epidemiology, Pathological and Clinical Features of 4307 Patients with Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN) of the Spanish Neuroendocrine Cancer Registry (R-GETNE)
    Garcia Carbonero, R.
    Jimenez-Fonseca, P.
    Benavent, M.
    Alonso, V
    Alonso, T.
    Carmona-Bayonas, A.
    Custodio, A.
    Ortiz de Solorzano, F. J.
    Diaz, J.
    Marazuela, M.
    Castano, A.
    Capdevila, J.
    NEUROENDOCRINOLOGY, 2020, 110 : 71 - 71
  • [7] Impact of KRAS and BRAF mutations on treatment efficacy and survival in high-grade gastroenteropancreatic neuroendocrine neoplasms
    Elvebakken, Hege
    Hjortland, Geir Olav
    Garresori, Herish
    Andresen, Per Arne
    Janssen, Emiel A. M.
    Vintermyr, Olav Karsten
    Lothe, Inger M. B.
    Sorbye, Halfdan
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 (04)
  • [8] Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
    Rosery, Vivian
    Mika, Stephan
    Schmid, Kurt Werner
    Reis, Henning
    Stuschke, Martin
    Treckmann, Jurgen
    Markus, Peter
    Schumacher, Brigitte
    Albers, David
    Mende, Bastian
    Lahner, Harald
    Wiesweg, Marcel
    Schuler, Martin
    Siveke, Jens T.
    Kasper, Stefan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 4315 - 4325
  • [9] Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
    Vivian Rosery
    Stephan Mika
    Kurt Werner Schmid
    Henning Reis
    Martin Stuschke
    Jürgen Treckmann
    Peter Markus
    Brigitte Schumacher
    David Albers
    Bastian Mende
    Harald Lahner
    Marcel Wiesweg
    Martin Schuler
    Jens T. Siveke
    Stefan Kasper
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 4315 - 4325
  • [10] Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
    Venizelos, Andreas
    Sorbye, Halfdan
    Elvebakken, Hege
    Perren, Aurel
    Lothe, Inger Marie B.
    Couvelard, Anne
    Hjortland, Geir Olav
    Sundlov, Anna
    Svensson, Johanna
    Garresori, Harrish
    Kersten, Christian
    Hofsli, Eva
    Detlefsen, Soenke
    Vestermark, Lene W.
    Ladekarl, Morten
    Tabaksblat, Elizaveta Mitkina
    Knappskog, Stian
    ENDOCRINE-RELATED CANCER, 2023, 30 (10)
12345